🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Chlorhexidine

    CRESCENT BIOPHARMA, INC.

    Neonatal Infections

    approved small molecule completed

    1 trial

  2. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  3. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    4 trials

  4. Cocaine-Related Disorders

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    2 trials

  5. Combination NRT (Nicotine patch, Nicotine lozenge)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  6. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  7. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  8. Dental foam "Biorepair PERIBIOMA"

    The First People's Hospital of Lianyungang

    Oral Health

    approved small molecule completed

    1 trial

  9. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  10. Dexmedetomidine

    BioXcel Therapeutics

    Schizophrenia Agitation

    approved small molecule active

    1 trial

  11. Dimethyl fumarate

    Biogen

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  12. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  13. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  14. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial

  15. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial

  16. Egg based influenza vaccines

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    approved mab active

    1 trial

  17. Electronic Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule active

    1 trial

  18. Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota, Double encapsulated oral transplant of fecal microbiota

    Pari Pharma GmbH

    Crohn’s disease

    approved small molecule active

    1 trial

  19. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial

  20. Erythromycin 4% topical gel formulation

    BRIGHT MINDS BIOSCIENCES INC.

    Acne Vulgaris

    approved small molecule active

    1 trial

  21. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  22. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  23. Fentanyl Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Function Loss

    approved small molecule active

    1 trial

  24. Filgotinib

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    approved small molecule active

    8 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources